Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Hagekyriakou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Letters|January 17, 2015
Building immunity to cancer with radiation therapySuresh J Haikerwal, Jim Hagekyriakou, Michael MacManus, et al.
Plos One|March 17, 2017
Follistatin attenuates radiation-induced fibrosis in a murine modelHelen B Forrester, David M de Kretser, Trevor Leong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptorBenjamin Solomon, Jim Hagekyriakou, Melanie K Trivett, et al.
Zeitschrift Fur Medizinische Physik|June 15, 2021
Contralateral breast dose with electronic compensators and conventional tangential fields - A clinical dosimetric studyPrabhakar Ramachandran, Amanda Smith, Jim Hagekyriakou, et al.
Stem Cells Translational Medicine|December 1, 2012
Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammationJordane Malaterre, Cameron S McPherson, Delphine Denoyer, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune DefensesJoseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Letters|January 17, 2015
Building immunity to cancer with radiation therapySuresh J Haikerwal, Jim Hagekyriakou, Michael MacManus, et al.
Plos One|March 17, 2017
Follistatin attenuates radiation-induced fibrosis in a murine modelHelen B Forrester, David M de Kretser, Trevor Leong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptorBenjamin Solomon, Jim Hagekyriakou, Melanie K Trivett, et al.
Zeitschrift Fur Medizinische Physik|June 15, 2021
Contralateral breast dose with electronic compensators and conventional tangential fields - A clinical dosimetric studyPrabhakar Ramachandran, Amanda Smith, Jim Hagekyriakou, et al.
Stem Cells Translational Medicine|December 1, 2012
Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammationJordane Malaterre, Cameron S McPherson, Delphine Denoyer, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune DefensesJoseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
Pageof 1